The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
NCT ID: NCT00175110
Last Updated: 2009-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
66 participants
INTERVENTIONAL
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hibiscus Sabdariffa on Blood Pressure in a University Population
NCT03804801
Effect of Standardized Hibiscus Sabdariffa Tea in Seemingly Healthy Human Volunteers
NCT04339283
Effect of Hibiscus and Lippia Extract on Blood Pressure
NCT03507023
Standardized Eucommia Extract in the Treatment of Hypertension
NCT00626132
Hibiscus Sabdariffa Extract Effect on Neuromuscular Performance
NCT05653076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
herbal therapy/botanical therapy (Hibiscus sabdariffa)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diastolic blood pressure 95 mm Hg or less
* Body mass index (BMI) 18.5-34.9 kg/m2
Exclusion Criteria
* Use of medications that influence blood pressure
* Cardiovascular disease
* Chronic kidney disease
* Diabetes
* Regular use of vitamin C supplements (min 500 mg/day) within prior 30 days
* Regular strenuous aerobic activity greater than 30 min/day
* Excessive intake of caffeine or alcohol
* Pregnancy within last 6 months or during study period
* Abnormal complete blood count (CBC), urinalysis or electrocardiogram (EKG)
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celestial Seasonings
INDUSTRY
Tufts Medical Center
OTHER
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tufts University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey B Blumberg, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Tufts Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010 Feb;140(2):298-303. doi: 10.3945/jn.109.115097. Epub 2009 Dec 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PV3727
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.